
ecib, Biotech training program
Compact advanced training for biopharma with laboratory training for employees of pharmaceutical companies without relevant biotechnology training
Compact advanced training for biopharma with laboratory training for employees of pharmaceutical companies without relevant biotechnology training
As secondary metabolites are produced with the purpose to confer a selective advantage of the host organism they are an excellent source of novel bioactive compounds with great therapeutic potential for e.g. anti-biotics, anti-viral drugs and biological fungicides.
Growth factors are essential components in cell culture medium for pharmacological products as well as for cultivated meat production and also pharmaceuticals on their own. Still, their application is hampered by their folding instability.
You want to save money on expensive fermentation processes and speed them up? Young and viable cells provide a better fermentation performance. acib’s technology rejuvenates your yeast culture to increase process productivity withouth affecting other parameters.
Immune evasion is a hallmark of cancer, contributing signifcantly to the progression of malignancies and associated mortalities. An interdisciplinary approach lead by acib can assess personalized treatment options for patients, as well as lay the foundation to designing novel treatments.
You want healthy drinks with all the valuable ingredients and a good taste, but without or at least with less sugar? The good news is: You are not alone! The bad news is: It’s difficult to achieve with current technologies … Let’s develop some better ones!
acib has developed a new diagnostic tool for early sepsis detection through novel biomarkers based on circulating-free nucleic acids. The test allows for detection of sepsis 2-3 days before first symptoms occur and shows >80% accuracy.
acib’s vision is a world without suffering and with affordable access to food and medicine for all the people on this world. acib’s mission is to enable cost-effective and environmentally friendly new processes and products through the development of new technologies.
Coating proteins are part of the extracellular matrix (ECM) and are widely used in the pharmaceutical industry, medicine, and research to improve the adhesion of mammalian cells to surfaces/tissues in vivo and in vitro. Of the several hundred ECM proteins, only a few proteins are widely used for coating, with little research into their optimization.
Are you looking for an eco-friendly approach to improve the functionality of your product? Or do you want to integrate a renewable bioresource into your production pipeline and increase its sustainability? Microalgae could be your solution.